389 related articles for article (PubMed ID: 8944320)
1. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species.
Lipton SA
Brain Pathol; 1996 Oct; 6(4):507-17. PubMed ID: 8944320
[TBL] [Abstract][Full Text] [Related]
2. Neuronal injury associated with HIV-1: approaches to treatment.
Lipton SA
Annu Rev Pharmacol Toxicol; 1998; 38():159-77. PubMed ID: 9597152
[TBL] [Abstract][Full Text] [Related]
3. HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.
Lipton SA
Mol Neurobiol; 1994; 8(2-3):181-96. PubMed ID: 7999315
[TBL] [Abstract][Full Text] [Related]
4. AIDS-related dementia and calcium homeostasis.
Lipton SA
Ann N Y Acad Sci; 1994 Dec; 747():205-24. PubMed ID: 7847672
[TBL] [Abstract][Full Text] [Related]
5. Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide.
Lipton SA; Yeh M; Dreyer EB
Adv Neuroimmunol; 1994; 4(3):181-8. PubMed ID: 7874385
[TBL] [Abstract][Full Text] [Related]
6. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists.
Lipton SA
Dev Neurosci; 1994; 16(3-4):145-51. PubMed ID: 7705221
[TBL] [Abstract][Full Text] [Related]
7. HIV-related neurotoxicity.
Lipton SA
Brain Pathol; 1991 Apr; 1(3):193-9. PubMed ID: 1669708
[TBL] [Abstract][Full Text] [Related]
8. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.
Yoshioka M; Bradley WG; Shapshak P; Nagano I; Stewart RV; Xin KQ; Srivastava AK; Nakamura S
Adv Neuroimmunol; 1995; 5(3):335-58. PubMed ID: 8748077
[TBL] [Abstract][Full Text] [Related]
9. Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway.
Chen W; Sulcove J; Frank I; Jaffer S; Ozdener H; Kolson DL
J Virol; 2002 Sep; 76(18):9407-19. PubMed ID: 12186923
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular mechanisms of neuronal cell death in HIV dementia.
Li W; Galey D; Mattson MP; Nath A
Neurotox Res; 2005 Oct; 8(1-2):119-34. PubMed ID: 16260390
[TBL] [Abstract][Full Text] [Related]
11. Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways.
Chen W; Tang Z; Fortina P; Patel P; Addya S; Surrey S; Acheampong EA; Mukhtar M; Pomerantz RJ
Virology; 2005 Mar; 334(1):59-73. PubMed ID: 15749123
[TBL] [Abstract][Full Text] [Related]
12. Pathways to neuronal injury and apoptosis in HIV-associated dementia.
Kaul M; Garden GA; Lipton SA
Nature; 2001 Apr; 410(6831):988-94. PubMed ID: 11309629
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis.
Kaul M; Lipton SA
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8212-6. PubMed ID: 10393974
[TBL] [Abstract][Full Text] [Related]
14. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of l -cysteine.
Yeh MW; Kaul M; Zheng J; Nottet HS; Thylin M; Gendelman HE; Lipton SA
J Immunol; 2000 Apr; 164(8):4265-70. PubMed ID: 10754324
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
17. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults.
Lipton SA
NeuroRx; 2004 Jan; 1(1):101-10. PubMed ID: 15717010
[TBL] [Abstract][Full Text] [Related]
18. [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system].
Merino JJ; Montes ML; Blanco A; Bustos MJ; Oreja-Guevara C; Bayon C; Cuadrado A; Lubrini G; Cambron I; Munoz A; Cebolla S; Gutierrez-Fernandez M; Bernardino JI; Arribas JR; Fiala M
Rev Neurol; 2011 Jan; 52(2):101-11. PubMed ID: 21271550
[TBL] [Abstract][Full Text] [Related]
19. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
Lipton SA
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
[TBL] [Abstract][Full Text] [Related]
20. Differential Effects of Pharmacologic and Genetic Modulation of NMDA Receptor Activity on HIV/gp120-Induced Neuronal Damage in an In Vivo Mouse Model.
Nakanishi N; Kang YJ; Tu S; McKercher SR; Masliah E; Lipton SA
J Mol Neurosci; 2016 Jan; 58(1):59-65. PubMed ID: 26374431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
